Lưu trữ — US — techcrunch
After Neuralink, Max Hodak is building something stranger
Max Hodak, co-founder of Science Corp. and former Neuralink president, is venturing into innovative territory with brain-computer interfaces (BCIs) that aim to reshape human cognition. He discusses the launch of a vision-restoring product, Prima, and the potential for technology to enhance consciousness and possibly blur the lines between human and machine. He predicts significant advancements by 2035.
Điểm chính
- Max Hodak co-founded Science Corp. after leaving Neuralink, focusing on developing advanced BCI products.
- Science Corp.'s first product, Prima, aims to restore vision for patients with macular degeneration using a chip implanted in the retina.
- The company has demonstrated success in clinical trials, with 80% of participants able to read again.
- Hodak expresses ambitions for future developments in gene therapy and neuron growth to further enhance cognition.
- Predictions include a potential future where consciousness could be uploaded, with significant implications for healthcare economics.
Vì sao quan trọng
- The rise of BCI technology aligns with the 2025 IT Trends, which emphasize advancements in AI, machine learning, and medical technology.
- Similar initiatives are being pursued globally, such as China's push to lead the BCI industry by 2030.
- Historically, brain-computer interfaces have existed, but advances in engineering and miniaturization are opening new possibilities.
Hodak's vision for Science Corp. reflects transformative possibilities in BCI technology, which could redefine human experience. Despite the potential benefits, ethical and economic challenges loom as society navigates the implications of enhanced cognition and healthcare access.